Join experts in this symposium to explore LNP formulation from preclinical screening to scalable GMP manufacturing and rational design enabling RNA delivery beyond the liver.

Day Three highlights PFAS biomonitoring, rapid screening of 900+ contaminants, regulated bioanalysis, oligonucleotide assays, and therapeutic charge variant profiling.

Take your peak analysis to the next level with advanced distribution tools and fitting strategies in ASTRA software.

Explore how spatial lipidomics with MALDI MS-Imaging uncovers prostate cancer heterogeneity and links lipid changes to proteomics insights, advancing cancer research workflows.

Master detection in Chromeleon CDS—learn to configure parameters, choose the right algorithms, and boost data accuracy. Live Q&A with Thermo Fisher experts.

Gain a deeper understanding of oligonucleotide analysis, together with optimized LC-MS techniques for effective development, characterization, and quantification.

Day Two explores advanced MS strategies for proteomics, glycoproteins, bioreactor monitoring, and single-cell metabolomics, featuring experts from pharma and academia.

AbbVie presents the development of an Open-Access LC-MS platform for medicinal chemistry projects, enabled by Agilent OpenLab CDS SDK integration.

Join Phenomenex’s Koen Askamp to explore normal-phase HPLC: how it works, when to apply it, key differences from reversed-phase, and how to overcome typical challenges.

Discover how to make changes to the LC system to increase its biocompatibility.